Parkinson's Disease and Parkinsonism Clinical Trials
4 recruiting trials for Parkinson's Disease and Parkinsonism. Eligibility criteria explained in plain English.
TrialFinderData lists 4 Parkinson's Disease and Parkinsonism clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by The University of Texas Health Science Center at San Antonio (1), Xuanwu Hospital, Beijing (1), University of Minnesota (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Polysomnography ON stimulation then OFF (device, 1 trial), followed by Polysomnography OFF stimulation then ON, Deep Brain Stimulation.
Track Parkinson's Disease and Parkinsonism trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Sensing in Sleep Deep Brain Stimulation
Participants in this study have Parkinson's Disease and already have a device, called the Percept RC Deep Brain Stimulation device implanted. People with Parkinson's disease often...
Neural Mechanisms and Clinical Applications of DBS for Modulating Sleep Dysregulation in PD
Parkinson's disease (PD) is a prevalent neurodegenerative disorder characterized by both motor and non-motor symptoms. Subthalamic nucleus (STN) deep brain stimulation (DBS)...
Sleep-specific DBS Therapy in Parkinson's Disease
Sleep-wake disturbances are a major factor associated with reduced quality of life of individuals with Parkinson's disease (PD), a progressive neurological disorder affecting...
NYSCF Scientific Discovery Biobank
The New York Stem Cell Foundation (NYSCF) Research Institute is performing this research to accelerate diverse disease research using cells from the body (such as skin or blood...
Explore Other Conditions
Frequently Asked Questions
There are currently 4 clinical trials for Parkinson's Disease and Parkinsonism, with 4 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Parkinson's Disease and Parkinsonism, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Parkinson's Disease and Parkinsonism, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.